Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt
| Status: | Completed |
|---|---|
| Conditions: | High Blood Pressure (Hypertension), Ocular |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/6/2019 |
| Start Date: | January 2012 |
| End Date: | September 2012 |
The main purpose of this prospective study is to demonstrate the therapeutic equivalence of
topical brinzolamide dosed three times daily compared with AzoptTM (brinzolamide ophthalmic
suspension 1%) dosed three times daily in IOP reduction in patients with POAG or OH.
topical brinzolamide dosed three times daily compared with AzoptTM (brinzolamide ophthalmic
suspension 1%) dosed three times daily in IOP reduction in patients with POAG or OH.
Inclusion Criteria:
- Male and females 18 years of age or older,
- diagnosed with primary open-angle glaucoma or ocular hypertension.
Exclusion Criteria:
- Patients with any form of glaucoma (such as secondary, congenital, juvenile or normal
tension glaucoma, angle closure glaucoma) in either eye other than primary open-angle
glaucoma,
- ocular hypertension.
We found this trial at
1
site
Click here to add this to my saved trials
